Trimi vs Hims vs Ro: Comparing GLP-1 Weight Loss Programs

If you are considering a telehealth weight loss program with GLP-1 medications, you have likely come across Trimi, Hims (Hims & Hers), and Ro as popular options. All three offer access to GLP-1 medications through telehealth consultations, but they differ meaningfully in medications offered, pricing models, clinical support depth, and overall approach. This comparison is written by the Trimi team, so we want to be upfront about that bias, but we will be as honest and transparent as possible, including acknowledging where competitors have genuine strengths.

Quick Comparison Overview

Note: Pricing and offerings change frequently. Visit each company's website for the most current information.

Medications Offered

Trimi

Trimi focuses on compounded semaglutide and compounded tirzepatide, providing access to both major GLP-1 medications at doses customized by the prescribing provider. The compounded medications are sourced from state-licensed 503A sterile compounding pharmacies. Having both semaglutide and tirzepatide available means providers can match patients to the most appropriate medication based on their health profile, weight loss goals, and response patterns.

Hims & Hers

In March and April 2026 announcements, Hims said its providers can prescribe Wegovy pills, Wegovy injections and Ozempic, and can send prescriptions for Zepbound and Foundayo to the LillyDirect pharmacy. In March 2026 it also said it would no longer advertise compounded GLP-1s; its August 2026 SEC earnings release says it offers compounded GLP-1 access on a limited scale. Hims operates at very large scale as a publicly traded company with multiple product lines beyond weight loss (hair loss, ED, skincare, mental health). This scale brings strong brand recognition and infrastructure but may mean less specialization in weight management specifically.

Where Hims excels: Brand recognition, established infrastructure, and a broad ecosystem of health products. If you already use Hims for other health needs, the consolidated platform may be convenient.

Ro

Ro (Roman Health Ventures Inc.) offers GLP-1 medications through its weight loss program. In 2026 announcements, Ro described that offering in terms of FDA-approved GLP-1 medications such as Wegovy, and it bills its membership separately from medication. Ro also operates at significant scale with a well-developed technology platform.

Where Ro excels: Well-developed technology platform and a comprehensive body program approach that extends beyond medication alone.

Clinical Support and Provider Access

This is where programs diverge most meaningfully, and where we believe Trimi's approach stands out:

Trimi's Approach

Trimi was built specifically around GLP-1 weight loss treatment. Our clinical model emphasizes:

• Dedicated providers: Clinicians who specialize in GLP-1 therapy and obesity medicine, not generalists rotating through multiple product lines.
• Ongoing support: Regular check-ins, dose adjustments, and lifestyle guidance as part of the standard program, not add-on services.
• Responsive communication: Access to your clinical team for questions about side effects, diet, dose timing, and other concerns.
• Personalized titration: Dosing plans tailored to individual tolerance and response rather than rigid protocols.

Hims and Ro Approach

Both Hims and Ro offer provider consultations as part of their programs. A common model for large-scale telehealth platforms involves asynchronous intake (you fill out a questionnaire), provider review and prescription, and periodic check-ins. This model is efficient and works well for many patients, particularly those who are self-directed and comfortable managing their own care with less frequent touchpoints.

Honest assessment: Both Hims and Ro have invested significantly in clinical quality and patient experience. The level of support you receive depends partly on the specific provider assigned to you and partly on how proactively you engage with the program. Some patients have excellent experiences with all three platforms; others feel they need more support than a large-scale model provides.

Pricing and Value

Price comparison in this space is genuinely difficult because programs bundle differently:

• Some include medication in the monthly subscription; others charge separately
• Dose-dependent pricing means cost increases as you titrate up
• Promotional pricing may not reflect long-term costs
• Insurance involvement (for brand-name options at Ro) adds another variable

Our honest recommendation: When comparing prices, calculate the total monthly cost at your expected maintenance dose including all fees (consultation, medication, shipping). Ask about price changes with dose increases. And consider the value of clinical support, as the cheapest program is not the best value if you need more guidance than it provides.

Program Philosophy Differences

Trimi: Specialized Weight Loss Focus

Trimi is built exclusively for GLP-1 weight management. Every aspect of the program, from provider training to patient communication to content and education, is designed around helping patients succeed with GLP-1 therapy specifically. This specialization means deeper expertise in the niche but a narrower product offering.

Hims: Consumer Health Ecosystem

Hims approaches weight loss as one of many consumer health categories. Their strength is in brand building, consumer experience, and platform scale. Weight loss is integrated into a broader health and wellness ecosystem that includes multiple condition areas. This can be advantageous for patients who want a single platform for multiple health needs.

Ro: Technology-Forward Health Platform

Ro's weight-loss program sits within a broader telehealth platform. In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy, and it bills its membership separately from medication.

Who Each Program Is Best For

Choose Trimi If:

• You want a program built specifically around GLP-1 weight loss
• Dedicated provider relationships and personalized clinical support matter to you
• You want access to both semaglutide and tirzepatide options
• You value a smaller, more focused program over a large-scale platform

Choose Hims If:

• You value strong brand recognition and established infrastructure
• You already use Hims for other health products and want a consolidated platform
• You prefer a consumer-grade digital experience with polished design and ease of use
• You are comfortable with a more self-directed approach to your treatment

Choose Ro If:

• You want a technology-forward, data-driven approach
• You want FDA-approved brand-name medications such as Wegovy
• You value a comprehensive "body program" that extends beyond just medication

Important Factors Beyond the Platform

Regardless of which platform you choose, several factors matter more than the company name on the box:

• Medication quality: Confirm the medication type and dispensing pharmacy. For compounded medication, ask about state licensing and documented quality controls; compounded preparations are not FDA-approved.
• Provider qualifications: Your prescribing provider should be licensed in your state and experienced with GLP-1 medications for weight loss.
• Realistic expectations: No program guarantees specific results. Average weight loss with GLP-1 medications is 15-22% over 12-18 months, but individual results vary widely.
• Long-term planning: Ask about maintenance strategies, dose reduction options, and what happens if you want to stop treatment. A good program plans for the long term, not just the first few months.
• Lifestyle support: Medication alone is not enough. The best programs integrate dietary guidance, exercise recommendations, and behavioral support.

What We Admire About Our Competitors

In the interest of transparency, here is what we genuinely respect about Hims and Ro:

• Hims: They have done an extraordinary job normalizing conversations about health conditions that were previously stigmatized. Their consumer marketing and product design are best-in-class, and they have made healthcare feel more accessible and less clinical for millions of people.
• Ro: Ro operates an established telehealth technology platform for prescription care.

Competition in this space ultimately benefits patients by driving innovation, improving quality, and applying downward pressure on pricing. We welcome it.

Getting Started

If you are ready to explore GLP-1 weight loss treatment, we encourage you to evaluate all your options. Compare pricing at your expected dose, ask about clinical support models, and choose the program that best matches your needs and preferences.

To learn more about Trimi specifically, visit our how it works page or browse our treatment options. Our team is happy to answer questions, even if you ultimately choose a different provider.

Frequently Asked Questions

Is Trimi better than Hims for weight loss?

"Better" depends on what you value. Trimi offers more specialized GLP-1 expertise and personalized provider support. Hims offers a broader health ecosystem, strong brand recognition, and polished consumer experience. Trimi offers compounded semaglutide and tirzepatide, which are not FDA-approved; in 2026 announcements, Hims said its providers can prescribe FDA-approved brand-name GLP-1s such as Wegovy and Ozempic, and its August 2026 SEC earnings release says it offers compounded GLP-1 access on a limited scale. Consider which approach aligns better with how you want to manage your care.

Which is cheaper: Trimi, Hims, or Ro?

Pricing varies by medication, dose, and plan structure, and all three companies update their pricing periodically. Calculate total monthly cost at your expected maintenance dose, including all fees. The cheapest option is not necessarily the best value if it provides less clinical support than you need. Visit each company's website for current pricing.

Do Trimi, Hims, and Ro offer the same medications?

No. Trimi offers compounded semaglutide and compounded tirzepatide, which are not FDA-approved. In March and April 2026 announcements, Hims said its providers can prescribe Wegovy and Ozempic and can send Zepbound and Foundayo prescriptions to the LillyDirect pharmacy; its August 2026 SEC earnings release says it offers compounded GLP-1 access on a limited scale. In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy. Medication availability varies by platform, state, and individual eligibility. Confirm specific medication availability directly with each provider.

Are online GLP-1 programs legitimate?

Legitimate telehealth GLP-1 programs involve licensed healthcare providers evaluating patients and prescribing medication when appropriate. Look for: licensed prescribers in your state, medication from an appropriately licensed pharmacy, with compounded preparations distinguished from FDA-approved finished drugs, transparent pricing, and ongoing clinical follow-up. Avoid programs that offer medication without a provider consultation or that do not require a prescription.

Can I switch from Hims or Ro to Trimi?

Yes. Switching between telehealth weight loss programs is straightforward. A Trimi provider will evaluate your history, current dose, and response, then continue your treatment plan or adjust as needed. There is no medical reason you cannot transfer care between qualified providers.

What should I look for in a GLP-1 weight loss program?

Key factors: (1) medication quality from state-licensed pharmacies, (2) licensed, experienced providers, (3) transparent pricing without hidden fees, (4) ongoing clinical support and dose adjustment, (5) lifestyle guidance beyond just medication, and (6) a long-term maintenance plan. Any program that treats GLP-1 therapy as a quick fix rather than a long-term health strategy should be approached with caution.